Scientist.com Raises $24M for “Pharma Markets” that Outsource R&D
Xconomy
MAY 15, 2017
In particular, he wants to sign up more pharmaceutical companies to use the Web-based platform, which enables CROs to bid on pharma research projects and automates the contracting process. Founding CEO Kevin Lustig said Scientist.com will use the additional cash to expand its operations. Lustig argued.
79 
Let's personalize your content